
CosmicTaco
Trump's Tariff Threat Shakes Indian Pharma
- Trump's proposed 25% tariff on pharmaceutical imports sent shockwaves through the market, causing significant drops in stock prices of major Indian drug manufacturers.
- Indian pharma companies, heavily reliant on US exports, face potential profitability impacts if tariffs are imposed, though they hope to pass costs to consumers.
- Industry experts remain optimistic, citing India's cost advantage and strong US-India ties as potential mitigating factors.
Source: Moneycontrol, Mint
5mo ago
Jobs
One interview, 1000+ job opportunities
Take a 10-min AI interview to qualify for numerous real jobs auto-matched to your profile 🔑+322 new users this month

You're early. There are no comments yet.
Be the first to comment.
Discover more
Curated from across